PharmaVoice

JUNE 13, 2023

Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

265

265

Pharmaceutical Technology

JUNE 12, 2023

On 9 May, National Fentanyl Awareness Day was observed in recognition of the US opioid crisis. Accordingly, the development of non-opioid painkillers is experiencing a surge in activity and despite numerous novel targets receiving high levels of attention, cannabinoids have emerged as strong favourites to replace opioid-related medications. The North American opioid epidemic highlights limitations in opioid use, such as the potential for drug abuse and overdose.

Immunity 143

Immunity Immunization Drug Development 143

Pharmaceutical Technology

JUNE 13, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s new drug application (NDA) for the combination of capivasertib and FASLODEX (fulvestrant), and granted it priority review. The combination therapy is intended to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in adult patients, after recurrence or progression on or after an endocrine-based regimen.

98

98

cureatr

JUNE 15, 2023

When it comes time for a patient to choose their healthcare provider, it's important for them to understand who they're choosing to help ensure they are getting the best care possible. One sure way for the patient to know what to expect from their provider is by reviewing rankings and ratings around quality measures before deciding.

Hospitals 86

Hospitals 86

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

JUNE 12, 2023

The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor - News - PharmaTimes

122

122

Pharma Times

JUNE 15, 2023

Researchers show silver retains antimicrobial activity for longer when it is infused into bioactive glass - News - PharmaTimes

102

102

STAT

JUNE 14, 2023

Endometriosis, a common gynecological condition, is one of health’s great mimickers. It can manifest as a variety of painful symptoms but evade detection on scans and examinations. And for the estimated 10% to 15% of women with endometriosis, it can take over a decade to get a diagnosis. Part of the lag is because researchers still don’t know exactly how endometriosis occurs, except that the flow of menstrual blood backward through the fallopian tubes plays a role in some cases.

275

275

ALiEM - Pharm Pearls

JUNE 15, 2023

Which cardiotoxic plant is shown? Lily of the valley Moonflower Morning glory Water hemlock White snakeroot Reveal the Answer 1. Lily of the Valley What type of plant is lily of the valley? Lily of the valley ( Convallaria majalis ) is a woodland perennial with a sweet scented, white bell-shaped flower. It blooms from April to June in North America and bears orange-red berries in July [1].

Hospitals 246

Hospitals 246

PharmaVoice

JUNE 16, 2023

Industry execs give voice to the “game changers” they believe would have the greatest impact on the healthcare ecosystem for all.

246

246

The Thyroid Pharmacist

JUNE 16, 2023

Over the past few years, my mission to help people recover from Hashimoto’s has become increasingly focused on using food as medicine (or food pharmacology) to address many of the root causes and symptoms of thyroid conditions. In addition to incorporating healing foods into my diet, I’ve also discovered many herbs and spices that can have profound benefits for healing.

Diabetes 116

Diabetes Dosage Compounding Immunity 116

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

JUNE 13, 2023

Police drug busts are strongly associated with a large and sudden spike in overdose deaths, according to a new study. In the week following a major opioid bust, fatal overdoses in the same neighborhood in Indianapolis doubled, the analysis showed. Calls to 911 and the use of naloxone , the overdose-reversal medication, also spiked.

363

363

BioPharma Dive

JUNE 14, 2023

The FDA last year turned back an approval request from the drug’s former developer, Levo Therapeutics. That biotech is now owned by Acadia, which will run a new study designed to boost its odds of success.

115

115

PharmaVoice

JUNE 12, 2023

Tris Pharma’s CEO is “betting the company” on a pain reliever with the power of an opioid and a lower chance of addiction.

246

246

Pharma Times

JUNE 13, 2023

525-patient trial intends to assess ‘complement activation’ during HD in patients with end stage renal failure - News - PharmaTimes

118

118

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

STAT

JUNE 13, 2023

CHICAGO — The American Medical Association on Tuesday strongly criticized the body mass index , urging doctors to de-emphasize its use in assessing health and obesity and acknowledging that the measurement has been used for “racist exclusion” and has caused “historical harm.” The AMA, one of the largest medical groups in the U.S., voted to adopt this policy during its annual meeting here.

341

341

European Pharmaceutical Review

JUNE 16, 2023

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. A fundamental part of the R&D process, clinical trials hold great potential in advancing the field — as long as these digital innovations are implemented.

Communication 111

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 111

BioPharma Dive

JUNE 15, 2023

Lilly will pay the genetic medicine specialist $60 million upfront to work together on a treatment targeting a risk factor known as Lp(a).

126

126

PhRMA

JUNE 14, 2023

The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. Recent data from IQVIA shows 340B grew 12.2% year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. drug market.

Drug Pricing 104

Drug Pricing 104

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JUNE 13, 2023

Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to be offered horseback riding than given full access to a common, highly effective addiction medication. According to a new research paper, just one out of every eight residential treatment facilities open to patients ages 16 or 17 offers full access to buprenorphine.

Inpatient 341

Inpatient 341

European Pharmaceutical Review

JUNE 13, 2023

A new therapeutic radionuclide facility, the world’s largest production site of lutetium-177, has opened in Germany. ITM Isotope Technologies Munich SE ( ITM )’s manufacturing plant in Neufahrn near Munich will produce the innovative medical isotope for targeted cancer therapies. “Radiopharmaceuticals are an essential new class of anti-cancer drugs that have the potential to improve therapy outcomes and quality of life for many patients.

105

105

BioPharma Dive

JUNE 12, 2023

Decentralized clinical trials (DCTs) bring many benefits to the clinical research process, and more importantly, the patients. However, it is important to remember the risks if there is no data security process in place.

107

107

Pharma Times

JUNE 14, 2023

Find out more about the PharmaTimes Communications Awards 2023 – key dates, categories and which charity we have partnered with this year!

Communication 107

Communication 107

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

STAT

JUNE 12, 2023

Brain responses to nutrients in the gut are impaired in people with obesity, and that doesn’t change even after they lose weight through changes in diet, a new study finds, adding to mounting research showing the complexity and persistence of the biological effects of obesity. Using brain imaging, researchers saw that when people without obesity received nutrients, they experienced reduced activity in areas of the brain involved in food intake, suggesting the brain is signaling to them th

306

306

European Pharmaceutical Review

JUNE 11, 2023

The US Food and Drug Administration (FDA) has approved commercial production at Bristol Myers Squibb’s newest cell therapy manufacturing facility in Devens, Massachusetts. The 244,000 square foot facility in Devens is BMS’ third commercial cell therapy facility in the US. It is located on the company’s existing Devens site, which has been developing, producing, and testing clinical and commercial medicines for over a decade.

105

105

BioPharma Dive

JUNE 12, 2023

DeSouza is departing unrepentant about his decision to close the Grail deal, telling colleagues his belief in the merger “remains unshakeable.

111

111

Pharma Times

JUNE 16, 2023

Company will gain access to a considerable pipeline of liquid products covering various disease areas - News - PharmaTimes

115

115

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

STAT

JUNE 13, 2023

This article was co-published with The Markup , a nonprofit newsroom that investigates how powerful institutions are using technology to change our society. Sign up for its newsletters here. Websites for mental health crisis resources across the country — which promise anonymity for visitors, many of whom are at a desperate moment in their lives — have been quietly sending sensitive visitor data to Facebook, The Markup has found.

302

302

European Pharmaceutical Review

JUNE 13, 2023

If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. The chikungunya vaccine candidate is the only one globally for which regulatory review processes are underway.

Immunization 105

Immunization Immunity Vaccines 105

Express Pharma

JUNE 16, 2023

In this video: Dr Sanjay Kumar Jain, President – India Operations, Amneal Pharmaceuticals Topic: Enabling and optimising operational excellence Key Takeaway: Performance management, leadership, people, culture, continous improvement, risk and quality management etc are some of the key enablers of operational excellence. The post Dr Sanjay Kumar Jain, President – India Operations, Amneal Pharmaceuticals appeared first on Express Pharma.

98

98

Pharmaceutical Technology

JUNE 16, 2023

France-based biotech company Osivax has thrown its hat into the influenza ring by dosing the first subject with its vaccine candidate OVX836. The Phase IIa trial (NCT05734040) in Australia will see a potential 500 volunteers given OVX836 in combination with quadrivalent influenza vaccines (QIVs). The developer has tested OVX836 in four completed clinical trials.

Vaccines 98

Vaccines Immunization Immunity 98

STAT

JUNE 16, 2023

Over the past several months, my conversations with colleagues in the Alzheimer’s field have featured an unusual sentiment: optimism inflected with worry. Optimism because, after years of failed studies and the disastrous accelerated approval of aducanumab, we’re enjoying a less than one-year-old streak of good news. The latest bright flash is the June 9 Food and Drug Administration hearing on the anti-amyloid antibody lecanemab (to be sold by Eisai as Leqembi).

Drug Pricing 300

Drug Pricing 300